Overview Apheresis Equipment Market:
The global apheresis equipment market is witnessing significant growth, driven by the rising prevalence of chronic diseases, increasing demand for blood and plasma donations, and advancements in medical technology. Apheresis equipment, used for separating specific blood components such as plasma, platelets, and white blood cells, plays a critical role in therapeutic treatments, transfusions, and research applications. The growing adoption of automated and efficient apheresis systems, along with the expansion of blood banks and healthcare facilities, is further fueling market growth. Additionally, the increasing focus on personalized medicine and supportive government initiatives to enhance blood collection and donation infrastructure are boosting demand. With ongoing technological innovations improving safety, efficiency, and ease of use, the apheresis equipment market is poised for steady expansion in the coming years.
The global apheresis equipment market size was valued at USD 2.83 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 5.67 Billion by 2033, exhibiting a CAGR of 7.63% from 2025-2033. North America currently dominates the market, holding a market share of 35.0% in 2024. The increased incidence of autoimmune and chronic diseases among global populations is impelling the market growth. Moreover, continuous technological advancements that enhance procedure safety, efficiency, and accuracy are supporting the market growth. Additionally, the enhancements in blood component collection and in therapeutic procedures are expanding the apheresis equipment market share.
Key Trends and Growth Drivers – Apheresis Equipment Market:
Rising Demand for Blood and Plasma Donations:
Increasing awareness about blood donation and the growing need for plasma-derived therapies are driving demand for apheresis equipment. Blood banks and healthcare facilities are adopting advanced devices to efficiently collect and separate blood components.
Technological Advancements in Apheresis Systems:
Continuous innovations, such as automated and user-friendly apheresis devices, are improving operational efficiency, safety, and accuracy. Integration of advanced software and monitoring systems ensures better process control, enhancing the overall adoption rate.
Growing Prevalence of Chronic Diseases:
The rising incidence of conditions such as cancer, autoimmune disorders, and hematological diseases is fueling the need for therapeutic apheresis procedures, which helps in managing and treating these illnesses effectively.
Expansion of Healthcare Infrastructure:
Increasing investments in hospitals, clinics, and specialized blood centers in both developed and emerging markets are boosting the adoption of apheresis equipment. This trend is further supported by government initiatives and funding programs promoting blood donation and transfusion services.
Focus on Personalized Medicine:
The shift toward personalized and precision medicine is encouraging the use of apheresis equipment for targeted therapies, such as stem cell collection and plasma-based treatments, driving market growth and innovation.
Rising Awareness and Training Programs:
Educational initiatives for healthcare professionals and public awareness campaigns are helping increase the utilization of apheresis procedures, which indirectly drives the demand for modern apheresis systems.
Request Sample URL: https://www.imarcgroup.com/apheresis-equipment-market/requestsample
Factors Affecting the Growth of the Apheresis Equipment Industry:
Rising prevalence of chronic diseases:
Chronic diseases such as cardiovascular disorders, diabetes, rheumatoid arthritis, and neurological disorders are increasing globally due to factors like aging populations, sedentary lifestyles, and poor dietary habits. Many of these conditions require blood purification treatments to manage symptoms or as a part of ongoing care, which can involve the use of apheresis equipment. For instance, therapeutic plasma exchange (TPE) is utilized in the treatment of autoimmune diseases to remove antibodies that are part of the disease process. As these chronic conditions rise in prevalence, the demand for apheresis treatments also increases, thereby impelling the market growth.
Advancements in apheresis technologies:
Technological advancements have significantly improved the efficiency, safety, and ease of use of apheresis equipment. Modern machines are capable of more precise separations of blood components and are increasingly automated to reduce the possibility of human error and contamination. Innovations such as continuous flow centrifugation and membrane filtration enhance the capability and efficiency of apheresis procedures, making treatments quicker and less burdensome for patients. These improvements increase the adoption of apheresis procedures by healthcare providers and make the treatments more acceptable and less intimidating for patients, thus contributing to the market expansion.
Increasing demand for plasma-derived biopharmaceuticals:
Plasma-derived medicinal products, including immunoglobulins, albumin, and clotting factors, are critical for treating various medical conditions ranging from immune deficiencies to trauma and burn recovery. The process of collecting high-quality plasma efficiently, a key ingredient for these biopharmaceuticals, relies heavily on apheresis equipment. The global rise in demand for these products, driven by better diagnostic facilities, greater disease awareness, and broader healthcare access, is compelling more biopharmaceutical companies to invest in plasma collection and is providing an impetus to the market growth.
Apheresis Equipment Market Report Segmentation:
By Product:
- Disposable Apheresis Kits
- Apheresis Machine
On the basis of product, the market is divided into disposable apheresis kits and apheresis machines.
By Application:
- Blood Collection
- Treatment
- Neurology
- Hematology
- Renal Diseases
- Others
Based on the application, the market is bifurcated into blood collection and treatment.
By Procedure:
- Plasmapherasis
- Plateletpherasis
- Erythrocytapheresis
- Leukapheresis
- Photopheresis
- Others
On the basis of procedure, the market is classified into plasmapherasis, plateletpherasis, erythrocyt apheresis, leukapheresis, photopheresis, and others.
By Technology:
- Membrane Filtration
- Centrifugation
Based on the technology, the market is segmented into membrane filtration and centrifugation.
By End User:
- Blood Collection Centers
- Hospitals and Clinics
- Others
On the basis of end-users, the market is divided into blood collection centers, hospitals and clinics, and others.
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Based on the region, the market is segregated into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
Speak an Analyst: https://www.imarcgroup.com/request?type=reportid=2387flag=C
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Asahi Kasei Corporation
- B. Braun Melsungen Aktiengesellschaft
- Baxter International Inc.
- Fresenius Kabi Aktiengesellschaft (Fresenius SE Co. KGaA)
- Haemonetics Corporation
- Hemacare Corporation (Charles River Laboratories Inc.)
- Kaneka Corporation
- Kawasumi Laboratories Inc.
- Medica SpA
- Nikkiso Co Ltd.
- Terumo BCT Inc. (Terumo Corporation)
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: (+1-201971-6302)
